Center on Early Life Origins of Disease, Department of Population, Family and Reproductive Health, Johns Hopkins University Bloomberg School of Public Health, 615 N. Wolfe Street, Baltimore, MD, 21205-2179, USA.
Department of Biostatistics, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA.
Clin Epigenetics. 2023 Apr 7;15(1):59. doi: 10.1186/s13148-023-01473-1.
In utero exposure to diabetes has been shown to contribute to preterm birth, though the underlying biological mechanisms are yet to be fully elucidated. Fetal epigenetic variations established in utero may be a possible pathway. This study aimed to investigate whether in utero exposure to diabetes was associated with a change in newborn DNA methylation, and whether the identified CpG sites mediate the association between diabetes and preterm birth in a racially diverse birth cohort population.
This study included 954 mother-newborn pairs. Methylation levels in the cord blood were determined using the Illumina Infinium MethylationEPIC BeadChip 850 K array platform. In utero exposure to diabetes was defined by the presence of maternal pregestational or gestational diabetes. Preterm birth was defined as gestational age at birth less than 37 weeks. Linear regression analysis was employed to identify differentially methylated CpG sites. Differentially methylated regions were identified using the DMRcate Package.
126 (13%) newborns were born to mothers with diabetes in pregnancy and 173 (18%) newborns were born preterm, while 41 newborns were born both preterm and to mothers with diabetes in pregnancy. Genomic-wide CpG analysis found that eighteen CpG sites in cord blood were differentially methylated by maternal diabetes status at an FDR threshold of 5%. These significant CpG sites were mapped to 12 known genes, one of which was annotated to gene Major Histocompatibility Complex, Class II, DM Beta (HLA-DMB). Consistently, one of the two identified significant methylated regions overlapped with HLA-DMB. The identified differentially methylated CpG sites mediated the association between diabetes in pregnancy and preterm birth by 61%.
In this US birth cohort, we found that maternal diabetes was associated with altered fetal DNA methylation patterns, which substantially explained the link between diabetes and preterm birth.
已有研究表明,子宫内暴露于糖尿病会导致早产,但其潜在的生物学机制尚未完全阐明。子宫内建立的胎儿表观遗传变化可能是一种可能的途径。本研究旨在调查子宫内暴露于糖尿病是否与新生儿 DNA 甲基化的变化有关,以及在种族多样化的出生队列人群中,鉴定出的 CpG 位点是否介导了糖尿病与早产之间的关联。
本研究纳入了 954 对母婴。使用 Illumina Infinium MethylationEPIC BeadChip 850K 阵列平台测定脐带血中的甲基化水平。子宫内暴露于糖尿病的定义为母亲存在妊娠前或妊娠期糖尿病。早产定义为出生时的胎龄小于 37 周。采用线性回归分析鉴定差异甲基化 CpG 位点。使用 DMRcate 包鉴定差异甲基化区域。
126 名(13%)新生儿的母亲在妊娠期间患有糖尿病,173 名(18%)新生儿早产,而 41 名新生儿同时早产且母亲在妊娠期间患有糖尿病。全基因组 CpG 分析发现,在 FDR 阈值为 5%的情况下,脐带血中有 18 个 CpG 位点因母亲的糖尿病状态而出现差异甲基化。这些显著的 CpG 位点映射到 12 个已知基因,其中一个注释为主要组织相容性复合体,类 II,DM 贝塔(HLA-DMB)。一致地,鉴定出的两个显著甲基化区域之一与 HLA-DMB 重叠。鉴定出的差异甲基化 CpG 位点通过 61%介导了妊娠糖尿病与早产之间的关联。
在本项美国出生队列研究中,我们发现母亲的糖尿病与胎儿 DNA 甲基化模式的改变有关,这极大地解释了糖尿病与早产之间的联系。